Institute Of Research Engineers & Doctors Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 17-11-2024
- Paid Up Capital ₹ 0.10 M
as on 17-11-2024
- Company Age 13 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 4.75%
(FY 2023)
- Profit -12.84%
(FY 2023)
- Ebitda -26.08%
(FY 2023)
- Net Worth 20.21%
(FY 2023)
- Total Assets -7.73%
(FY 2023)
About Institute Of Research Engineers & Doctors
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Lovenish Seth, Mankesh Dadhwal, Santosh Jaiswal, and One other member serve as directors at the Company.
- CIN/LLPIN
U80301PB2011PTC035678
- Company No.
035678
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Nov 2011
- Date of AGM
27 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Rupnagar, Punjab, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Institute Of Research Engineers & Doctors?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lovenish Seth  | Additional Director | 03-Feb-2024 | Current |
| Mankesh Dadhwal | Director | Current | |
| Santosh Jaiswal | Additional Director | Current | |
| Shilpa Dadhwal | Additional Director | Current |
Financial Performance of Institute Of Research Engineers & Doctors.
Institute Of Research Engineers & Doctors Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.75% increase. The company also saw a substantial fall in profitability, with a 12.84% decrease in profit. The company's net worth Soared by an impressive increase of 20.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Institute Of Research Engineers & Doctors?
In 2021, Institute Of Research Engineers & Doctors had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Caelius Consulting It Services Private LimitedActive 5 years 3 monthsMankesh Dadhwal is a mutual person
- Caelius Cares For Sustainable Future FoundationActive 4 months 6 days
Mankesh Dadhwal and Shilpa Dadhwal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Institute Of Research Engineers & Doctors?
Unlock and access historical data on people associated with Institute Of Research Engineers & Doctors, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Institute Of Research Engineers & Doctors, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Institute Of Research Engineers & Doctors's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
